Cantor Fitzgerald Increases National Health Investors (NHI) Price Target to $80.00
National Health Investors (NYSE:NHI) had its price target hoisted by stock analysts at Cantor Fitzgerald from $75.00 to $80.00 in a research note issued on Wednesday. The brokerage presently has a “neutral” rating on the real estate investment trust’s stock. Cantor Fitzgerald’s target price suggests a potential upside of 4.51% from the company’s current price.
Several other analysts have also recently issued reports on the company. KeyCorp decreased their price objective on National Health Investors from $70.00 to $60.00 and set a “sell” rating on the stock in a report on Tuesday, April 17th. Wells Fargo & Co set a $75.00 price target on National Health Investors and gave the company a “market perform” rating in a report on Thursday, May 31st. They noted that the move was a valuation call. Zacks Investment Research upgraded National Health Investors from a “hold” rating to a “buy” rating and set a $83.00 price target on the stock in a report on Wednesday, July 25th. Capital One Financial upgraded National Health Investors from an “equal weight” rating to an “overweight” rating in a report on Friday, May 11th. Finally, SunTrust Banks restated a “hold” rating and set a $79.00 price target on shares of National Health Investors in a report on Wednesday. They noted that the move was a valuation call. One research analyst has rated the stock with a sell rating, seven have given a hold rating and five have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $75.44.
Shares of NHI traded down $1.46 during mid-day trading on Wednesday, hitting $76.55. 33,560 shares of the stock were exchanged, compared to its average volume of 154,820. The stock has a market capitalization of $3.16 billion, a price-to-earnings ratio of 14.36, a price-to-earnings-growth ratio of 3.50 and a beta of 0.43. National Health Investors has a 52-week low of $62.71 and a 52-week high of $81.60. The company has a debt-to-equity ratio of 0.88, a current ratio of 15.21 and a quick ratio of 15.21.
A number of large investors have recently added to or reduced their stakes in NHI. Assetmark Inc. raised its holdings in National Health Investors by 370.3% during the 1st quarter. Assetmark Inc. now owns 2,215 shares of the real estate investment trust’s stock valued at $149,000 after buying an additional 1,744 shares during the period. Zeke Capital Advisors LLC purchased a new stake in National Health Investors during the 2nd quarter valued at $201,000. Neuberger Berman Group LLC purchased a new stake in National Health Investors during the 1st quarter valued at $227,000. Botty Investors LLC bought a new position in National Health Investors in the 1st quarter valued at $237,000. Finally, Cornerstone Wealth Management LLC bought a new position in National Health Investors in the 2nd quarter valued at $265,000. Institutional investors own 70.42% of the company’s stock.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
See Also: How to Use the New Google Finance Tool
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.